Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section
Recruiting
N/A
Interventional Study
Ondansetron
Lozenge
Intravenous
Prevention
Shivering
Cesarean Section
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 40
- Sex
- Female
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 90 (estimated)
- Sponsor
- Tanta University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to compare the effect of ondansetron lozenge and intravenous for prevention of shivering in cesarean section (CS).
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age from 18 to 40 years.
* American Society of Anesthesiology (ASA) physical status II.
* Parturient women undergoing cesarean section under spinal anesthesia.
Exclusion Criteria:
* Parturient women with any contraindication or hypersensitivity to the study drugs.
* Any hist…
Contacts